Background Histological evaluation by liver biopsy is considered the gold standard for
assessing liver disease; however, it is highly invasive. Non-invasive liver stiffness …

作者贡献分布: 苏倩, 徐楠与谢琴秀对此文所作贡献三均等; 本课题由郜玉峰设计;
研究过程由李影, 苏倩, 徐楠, 谢琴秀, 郜玉峰完成; 数据分析由韩可兴完成; 论文写作由李影完成 …

Fatty liver disease is an important cause of chronic liver disease affecting one quarter of the
world's population. There is debate regarding the most appropriate name and definition for …

We thank Binet et al. for their comments regarding our recently published manuscript
characterizing the prevalence of NAFLD, advanced fibrosis and cirrhosis in a prospectively …

Background: This study aimed to explore the effectiveness of endoscopic ultrasound
elastography (EUS-EG) in evaluating liver fibrosis. Methods: The present study involved 11 …

The search for reliable and non-invasive biomarkers of liver fibrosis has been a focus of
intense medical research, with the aim of improving patient outcomes through early …

Alcohol-related liver disease is present in 4–9% of the population and occurs after years of
excessive drinking. Liver cirrhosis develops after decades of heavy drinking, but the …

Non-alcoholic fatty liver disease (NAFLD) is the leading cause of chronic liver disease
globally. 1, 2 It is commonly associated with obesity, dyslipidemia, insulin resistance …

Cystic fibrosis-related hepatobiliary involvement (CFHBI) is a term used to describe a
spectrum of hepatobiliary involvement ranging from benign elevation of transaminase levels …

Nonalcoholic fatty liver disease, hereafter referred to simply as fatty liver disease, is the most
widespread liver disease, with an estimated prevalence of 38% of the global adult …